Compare SOFI & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SOFI | STE |
|---|---|---|
| Founded | 2011 | 1985 |
| Country | United States | United States |
| Employees | N/A | 3700 |
| Industry | Diversified Financial Services | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.2B | 22.1B |
| IPO Year | 2020 | 2018 |
| Metric | SOFI | STE |
|---|---|---|
| Price | $13.40 | $254.82 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 25 | 8 |
| Target Price | $20.84 | ★ $281.14 |
| AVG Volume (30 Days) | ★ 48.3M | 713.0K |
| Earning Date | 10-27-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 1.08% |
| EPS Growth | N/A | ★ 27.90 |
| EPS | 0.41 | ★ 7.93 |
| Revenue | $619,353,000.00 | ★ $5,935,900,000.00 |
| Revenue This Year | $41.05 | $7.57 |
| Revenue Next Year | $26.85 | $7.05 |
| P/E Ratio | $32.98 | ★ $32.13 |
| Revenue Growth | ★ 23.10 | 8.73 |
| 52 Week Low | $13.52 | $195.14 |
| 52 Week High | $30.42 | $269.44 |
| Indicator | SOFI | STE |
|---|---|---|
| Relative Strength Index (RSI) | 33.11 | 62.00 |
| Support Level | N/A | $212.26 |
| Resistance Level | $19.18 | $257.45 |
| Average True Range (ATR) | 0.76 | 6.91 |
| MACD | -0.29 | 0.23 |
| Stochastic Oscillator | 1.84 | 68.38 |
SoFi is a financial-services company that was founded in 2011 and is based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020, the company also offers payment and account services for debit cards and digital banking.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.